| Literature DB >> 31564820 |
Rolake O Alabi1, Zachary A Turnbull2, Peter G Coombs1, Yiyuan Wu3, Anton Orlin1, Rv Paul Chan4, Szilard Kiss1, Donald J D'Amico1, Mrinali P Gupta1.
Abstract
PURPOSE: To determine rates of intraoperative and postoperative systemic and ocular adverse events and establish the value of preoperative medical assessment in patients undergoing surgery for primary rhegmatogenous retinal detachment repair at a single academic center. PATIENTS AND METHODS: Retrospective cohort study of 185 patients undergoing surgery for repair of primary rhegmatogenous retinal detachment (RRD) at a single academic center. Medical records were reviewed for medical comorbidities, completion of preoperative medical examination, anesthesia used during surgery, intraoperative adverse medical events, intraoperative ocular complications, and systemic and ocular postoperative complications. The main outcome of interest was the association of comorbidities and preoperative medical evaluation with intraoperative and postoperative complications.Entities:
Keywords: adverse medical events; postoperative systemic adverse events; preoperative assessment; preoperative medical testing; retinal detachment; vitreoretinal surgery
Year: 2019 PMID: 31564820 PMCID: PMC6732513 DOI: 10.2147/OPTH.S209681
Source DB: PubMed Journal: Clin Ophthalmol ISSN: 1177-5467
Patient characteristics: demographics
| Sex | n (%) |
|---|---|
| Male | 131 (68) |
| Female | 62 (32) |
| Age, years | 52.2±17.7 |
| ≤17-year-old | 8 (4) |
| 18–50-year-old | 68 (35) |
| ≥50-year-old | 117 (61) |
Patient characteristics: medical comorbidities
| Comorbidity | n (%) |
|---|---|
| Hypertension | 60 (31) |
| Coronary artery disease | 18 (9) |
| Congestive heart failure | 3 (2) |
| Arrhythmia | 6 (3) |
| Diabetes mellitus | 17 (9) |
| Lung disease | 15 (8) |
| Transient ischemic attack | 2 (1) |
| Stroke | 0 (0) |
| Chronic renal failure | 4 (2) |
| Cancer (all) | 20 (10) |
| Current smoker | 13 (7) |
| Prior smoker | 43 (22) |
| Never smoker | 132 (68) |
Note: aSmoking history unknown in 5 cases.
Preoperative assessment characteristics
| Macula status | n (%) |
|---|---|
| Macula-on | 77 (40) |
| Macula-off | 116 (60) |
| Average time from diagnosis to surgery, Mac on (days) | 4±9 |
| Median | 1 |
| Mode | 0 |
| Average time from diagnosis to surgery, Mac off (days) | 6±13 |
| Median | 1 |
| Mode | 1 |
| Initial encounter settinga | |
| Clinic | 152 (79) |
| Emergency room | 36 (19) |
| In-patient | 3 (2) |
Note: aEncounter setting unknown in 2 cases.
Surgical characteristics
| Surgery type | n (%) |
|---|---|
| Pars plana vitrectomy (PPV) | 132 (68) |
| Scleral buckle (SB) | 40 (21) |
| SB+PPV | 21 (11) |
| General anesthesia | 40 (21) |
| Monitored anesthesia care | 153 (79) |
| None | 35 (18) |
| Retrobulbar | 140 (73) |
| Subtenon | 4 (2) |
| Peribulbar | 14 (7) |
Preoperative clearance
| Overall | n (%) |
|---|---|
| Cleared | 69 (36) |
| Not cleared | 124 (64) |
| Cleared, age≤17-year-old | 8 (100) |
| Cleared, age, 18–50-year-old | 24 (35) |
| Cleared, age≥50-year-old | 37 (32) |
| Cleared, macula-on | 21 (27) |
| Cleared, macula-off | 48 (41) |
Note: aP<0.05 using chi-squared test (Prism 6) comparing macula-on and macula-off cases with or without preoperative clearance.
Intraoperative adverse events or complications
| Intraoperative complications | n (%) |
|---|---|
| Bradycardia or tachycardiaa | 4 (2) |
| Hypotensionb | 4 (2) |
| Hypertensionc | 2 (1) |
| Arrhythmia | 0 (0) |
| Myocardial infarction | 0 (0) |
| Congestive heart failure flare | 0 (0) |
| Desaturation | 0 (0) |
| Respiratory complications | 0 (0) |
| Respiratory failured | 0 (0) |
| Stroke/CVA | 0 (0) |
| Hypoglycemia | 0 (0) |
| Hyperglycemia | 1 (0.5) |
| Inability to extubate (general anesthesia cases) | 0 (0) |
| Postoperative hospitalizations | 0 (0) |
| Death | 0 (0) |
Notes: aBradycardia or tachycardia requiring intervention. bHypotension defined as BP<100 systolic with symptoms or requiring intervention. cHypertension requiring intervention. dRespiratory failure requiring ventilation.
Other associated complications
| Ocular complications | n (%) |
|---|---|
| Intraoperativea | 1 (0.5) |
| Postoperativeb | 1 (0.5) |
| Postoperativec | 2 (1) |
Notes: aIntraoperative ocular complication was choroidal hemorrhage. bPostoperative ocular complication was vitreous hemorrhage. cPostoperative systemic complications (2) were fevers with myalgias (1) and deep vein thrombosis and pulmonary embolism (1).
Relationship between preoperative comorbidities and characteristics and any intraoperative and postoperative adverse events
| Preoperative comorbidity | OR | 95% CI of OR | |
|---|---|---|---|
| Hypertension | 1.54 | 0.48–4.56 | 0.56 |
| Cardiac disease (all)a | 3.48 | 0.86–11.7 | 0.06 |
| Coronary artery disease | 1.64 | 0.22–6.81 | 0.64 |
| Chronic heart failure | 24.5 | 1.88–802 | 0.02 |
| Arrhythmia | 6.77 | 0.78–40.6 | 0.07 |
| Lung disease | 2.05 | 0.27–8.73 | 0.33 |
| Diabetes | 0.81 | 0.03–4.54 | 1.00 |
| Age, years | 1.01 | 0.98–1.04 | 0.63 |
| Sexb | 1.08 | 0.31–3.23 | 1.00 |
| Smoking history | |||
| Current smoker | 2.92 | 0.37–14.0 | 0.26 |
| Prior smoker | 1.61 | 0.40–5.54 | 0.26 |
| History of anticoagulant usec | 6.77 | 0.78–40.6 | 0.07 |
| General anesthesia | 9.56 | 3.11–33.4 | <0.001 |
| Preoperative medical clearance | 1.64 | 0.54–4.85 | 0.52 |
Notes: Adverse events defined as all intraoperative and postoperative systemic and ocular complications. All patients with complications had no history of chronic renal failure or malignancy. No patients in cohort presented with history of stroke. aAll patients with history of at least one of following conditions: coronary artery disease, myocardial infarction, congestive heart failure, arrhythmia, or other structural or valvular heart disease. bDenotes odds ratio of being female relative to being male. cHistory of anticoagulant use refers to documented history of taking any anticoagulation agent (ie, warfarin or non-vitamin K antagonist oral anticoagulants, NOACs) prior to surgery. The retrospective review was limited in its ability to reveal if, and for how long, anticoagulation agents were held prior to operations.